Market Tracker

12/19 6:05pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

5.41
Data as of Dec 19
 -0.25 / -4.42%
Today’s Change
4.88
Today|||52-Week Range
31.73
-64.94%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close5.66
Today’s open5.58
Day’s range5.41 - 5.70
Volume67,577
Average volume (3 months)43,634
Market cap$58.4M
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-5.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
BLRXBioLine RX Ltd+0.03+1.78%
PARNParnell Pharmaceutic...+0.60+15.87%
ACSTAcasti Pharma Inc-0.01-1.41%
ADMPAdamis Pharmaceutica...-0.04-0.73%
Data as of 3:59pm ET, 12/19/2014

Financials

Next reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$5.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts